During the past decade, James Lind Centro de Investigación Del Cáncer conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "James Lind Centro de Investigación Del Cáncer" #1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "James Lind Centro de Investigación Del Cáncer" are "Cancer of Unknown Primary Site" (1 trials), "Non-Small Cell Lung Cancer" (1 trials), "Non-small Cell Lung Cancer" (1 trials) and "Triple Negative Breast Neoplasms" (1 trials). Many other conditions were trialed in "James Lind Centro de Investigación Del Cáncer" in a lesser frequency.

Most popular intervention types in "James Lind Centro de Investigación Del Cáncer" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Alectinib" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "James Lind Centro de Investigación Del Cáncer" are 4 trials for "All" genders.

Currently, there are NaN active trials in "James Lind Centro de Investigación Del Cáncer". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in James Lind Centro de Investigación Del Cáncer, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in James Lind Centro de Investigación Del Cáncer, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".